The Net Margin of Kolon Life Science Inc (102940.KQ) is -57.68%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -57.68% |
| 2023-12-31 | -24.65% |
| 2022-12-31 | 1.11% |
| 2021-12-31 | -0.83% |
| 2020-12-31 | -33.38% |
| 2019-12-31 | -62.15% |
| 2018-12-31 | -38.20% |
| 2017-12-31 | -1.19% |
| 2016-12-31 | 8.00% |
| 2015-12-31 | 0.66% |